Reproducible induction of 'atypical' Torsades de Pointes by programmed electrical stimulation: A novel form of sotalol-induced proarrhythmia?

Journal of Cardiovascular Electrophysiology

Volumn 8, Issue 9, 1997, Pages 1055-1061

  Krishnan, Subramaniam C ^a   Galvin, Joseph ^a   McGovern, Brian ^a   Garan, Hasan ^a   Ruskin, Jeremy N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Polymorphic ventricular tachycardia; Proarrhythmia; Sotalol

Indexed keywords

GLYCERYL TRINITRATE; METOPROLOL; SOTALOL;

ADULT; ARRHYTHMOGENESIS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TORSADE DES POINTES;

EID: 0030886479     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1997.tb00629.x     Document Type: Article

References (36)

1. The Cardiac Arrhythmia Suppression Trial Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412.
2. Mason J: A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458.
3. Hornloser SH, Arendts W, Quart B: Torsades de pointes during sotalol therapy. (Abstract) Am J Cardiol 1992;13(Suppl):305.
4. Soyka LF, Wirtz C, Spangenberg R: Clinical safety profile of sotalol in patients with arrhythmias. Am J Cardiol 1990;65(Suppl):74A-81A.
5. Desertenne F: La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur 1966;59:263-272.
6. Waldo AL, Camm AJ, deRuyter H, et al: Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12.
7. Jackman WM, Friday KJ, Anderson JL, et al: The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;31:115-172.
8. Burashnikov A, Antzelevitch C: Acceleration-induced early afterdepolarization and triggered activity. Circulation 1995;92:1-434.
9. Habbah MA, El-Sherif N: TU alternans, long QTU, and torsades de pointes: Clinical and experimental observations. PACE 1992;15:916-931.
10. Locati EH, Maison-Blanche P, Dejode P, et al: Spontaneous sequences of onset of torsades de pointes in patients with acquired prolonged repolarization: Quantitative analysis of Holter recordings. J Am Coll Cardiol 1995;25:1564-1575.
11. Vos M, Verduyn C, Gorgels APM, et al: Reproducible induction of early afterdepolarizations and torsades de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995; 91:864-872.
12. Brugada P, Green M, Abdollah H, et al: Significance of ventricular arrhythmias initiated by programmed ventricular stimulation: The importance of the type of ventricular arrhythmias induced and the number of premature stimuli required. Circulation 1984;69:87.
13. Josephson M: Use of electrophysiological testing to select antiarrhythmic drug therapy for ventricular arrhythmias. In Rosen MR, Janse MJ, Wit AL, eds. Cardiac Electrophysiology: A Textbook. Futura Publishing Co., Inc.. Mount Kisco, NY, 1990, pp. 1137-1158.
14. Buxton AE, Marchlinski FE, Miller JM, et al: The role of procainamide in identifying clinically relevant polymorphic tachycardias. Circulation 1988;78:11-71.
15. Horowitz LN, Greenspan AM, Spielman SR, et al: Torsades de pointes: Electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation 1981;63:1120-1128.
16. Bigger JT, Sahar D: Clinical types of proarrhythmic response to antiarrhythmic drugs. Am J Cardiol 1987;59: 2E-5E.
17. Horowitz LN, Greenspan AM, Rae AP, et al: Proarrhythmic responses during electrophysiologic testing. Am J Cardiol 1987;59:45E-48E.
18. Zipes D: Proarrhythmic responses of antiarrhythmic drugs. Am J Cardiol 1987;59:26E-31E.
19. Morganroth JL, Horowitz L: Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol 1984;53:89B-94B.
20. Podrid PJ, Lampert S, Graboys TB, et al: Aggravation of arrhythmias by antiarrhythmic drugs - Incidence and predictors. Am J Cardiol 1987;59:38E-44E.
21. Slama R, Coumel P, Motte G, et al: Tachycardies ventriculaires et torsades de pointes: Frontieres morphologiques entre les dysrhythmies ventriculaires. Arch Mal Coeur 1973;66:1401-1411.
22. Krikler DM, Curry P: Torsades de pointes an atypical ventricular tachycardia. Br Heart J 1976;38:117-120.
23. Antzelevitch C, Sun Z, Zhang Z, et al: Cellular and ionic mechanisms underlying erythromycin-induced long QT and torsades de pointes. J Am Coll Cardiol 1997; (In press).
24. Burashnikov A, Antzelevitch C: Mechanism of acceleration-induced early afterdepolarization activity and action potential prolongation in tissues isolated from the M region of the canine ventricle. (Abstract) PACE 1996;19:645.
25. Weissenburger J, Nesterenko V, Antzelevitch C: M cells contribute to transmural dispersion of repolarization and to development of torsade de pointes in the canine heart in vivo. (Abstract) PACE 1996;19:707.
26. Coumel P. Early afterdepolarizations and triggered activity in clinical arrhythmias. In Rosen MR, Janse MJ, Wit AL, eds. Cardiac Electrophysiology: A Textbook. Futura Publishing Co., Inc., Mount Kisco, NY, 1990, pp. 387-411.
27. El-Sherif N, Zeiler RH, Craelius W, et al: QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Circ Res 1988;63:286-305.
28. Roden DM, Hoffman B: Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibres: Relationship of potassium and cycle length. Circ Res 1985;56: 857-867.
29. Brugada P, Wellens H: Early afterdepolarizations: Role in conduction block, "prolonged repolarizationdependent reexcitation" and tachyarrhythmias in the human heart. PACE 1985;8:889-896.
30. Coumel P, Leclercq JF, Lucet V: Possible mechanisms of the arrhythmias in the long QT syndromes. Eur Heart J 1985;7:115-129.
31. Surawicz B: Electrophysiologic substrate of torsades de pointes. Dispersion of repolarization or early afterdepolarizations. J Am Coll Cardiol 1989;14:172-184.
32. Antzelevitch C, Sicouri S, Litovsky S, et al: Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 1991;69:1427-1449.
33. El-Sherif N, Restivo M: The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. Circ Res 1996;79:474-492.
34. Morady F, DiCarlo LA, Krol RB, et al: Effect of programmed ventricular stimulation on myocardial lactate extraction in patients with and without coronary artery disease. Am Heart J 1986;111:252-257.
35. Morady F, DiCarlo LA, Krol RB, et al: Role of myocardial ischemia during programmed stimulation in survivors of cardiac arrest with coronary artery disease. J Am Coll Cardiol 1987;9:1004-1012.
36. Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 reentry? Circulation 1993;87:562-572.